Short answer
iRhythm Holdings, Inc. (IRTC) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $224M (up 20.1% year over year) with net income of −$381,000.
Q2 2026 key financials · XBRL
- Revenue
- $224M
- +20.1% YoY · +12.4% QoQ
- Net income
- −$381,000
- +97.3% YoY · +97.3% QoQ
- Operating margin
- -1.1%
- Gross margin
- 72.8%
- EPS (diluted)
- −$0.01
- +97.7% YoY · +97.7% QoQ
Source: XBRL data from the iRhythm Holdings, Inc. (IRTC) Q2 2026 10-Q on SEC EDGAR. USD.
iRhythm Holdings, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Medicare reimbursement risk: 26% of revenue from CMS, with remote-testing IDTF rules still incomplete
- LCD regulatory risk: June 2026 final policies eliminated attended monitoring for Holter monitors
- Billing compliance risk: CPT-code interpretation could challenge Zio AT’s MCT reimbursement eligibility
- Competitive risk: Apple, Fitbit, Samsung and large device companies expanding cardiac-monitoring offerings
- Revenue concentration risk: iRhythm Services remain the company’s only current offerings
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other iRhythm Holdings, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.